Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
39,828,501
-
Shares change
-
+10,461,951
-
Total reported value, excl. options
-
$1,401,617,459
-
Value change
-
+$384,378,297
-
Number of buys
-
91
-
Number of sells
-
-32
-
Price
-
$35.19
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2020
127 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q3 2020.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,828,501 shares
of 202,731,676 outstanding shares and own 19.65% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (7,510,412 shares), BlackRock Inc. (3,529,141 shares), VANGUARD GROUP INC (3,180,644 shares), Cormorant Asset Management, LP (1,637,951 shares), Polar Capital LLP (1,569,212 shares), Point72 Asset Management, L.P. (1,513,266 shares), PERCEPTIVE ADVISORS LLC (1,400,000 shares), PICTET ASSET MANAGEMENT LTD (1,316,658 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,305,000 shares), and BVF INC/IL (1,198,427 shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.